These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 26431845)

  • 21. The development and validation of the Leiden Bother and Needs Questionnaire for patients with pituitary disease: the LBNQ-Pituitary.
    Andela CD; Scharloo M; Ramondt S; Tiemensma J; Husson O; Llahana S; Pereira AM; Kaptein AA; Kamminga NG; Biermasz NR
    Pituitary; 2016 Jun; 19(3):293-302. PubMed ID: 26809957
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Disease-specific quality of life evaluation and its determinants in Cushing's syndrome: what have we learnt?
    Badia X; Valassi E; Roset M; Webb SM
    Pituitary; 2014 Apr; 17(2):187-95. PubMed ID: 23564339
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Validation of the Tuebingen CD-25 Inventory as a Measure of Postoperative Health-Related Quality of Life in Patients Treated for Cushing's Disease.
    Milian M; Kreitschmann-Andermahr I; Siegel S; Kleist B; Führer-Sakel D; Honegger J; Buchfelder M; Psaras T
    Neuroendocrinology; 2015; 102(1-2):60-7. PubMed ID: 25968090
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Acquired prolactin deficiency (APD) after treatment for Cushing's disease is a reliable marker of irreversible severe GHD but does not reflect disease status.
    Mukherjee A; Murray RD; Teasdale GM; Shalet SM
    Clin Endocrinol (Oxf); 2004 Apr; 60(4):476-83. PubMed ID: 15049963
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Impaired quality of life, but not cognition, is linked to a history of chronic hypercortisolism in patients with Cushing's disease in remission.
    Pupier E; Santos A; Etchamendy N; Lavielle A; Ferriere A; Marighetto A; Resmini E; Cota D; Webb SM; Tabarin A
    Front Endocrinol (Lausanne); 2022; 13():934347. PubMed ID: 36004342
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Long-term negative impact on quality of life in patients with successfully treated Cushing's disease.
    Heald AH; Ghosh S; Bray S; Gibson C; Anderson SG; Buckler H; Fowler HL
    Clin Endocrinol (Oxf); 2004 Oct; 61(4):458-65. PubMed ID: 15473878
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Levoketoconazole improves clinical signs and symptoms and patient-reported outcomes in patients with Cushing's syndrome.
    Geer EB; Salvatori R; Elenkova A; Fleseriu M; Pivonello R; Witek P; Feelders RA; Bex M; Borresen SW; Puglisi S; Biller BMK; Cohen F; Pecori Giraldi F
    Pituitary; 2021 Feb; 24(1):104-115. PubMed ID: 33216275
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Quality of life in Cushing's syndrome.
    Santos A; Crespo I; Aulinas A; Resmini E; Valassi E; Webb SM
    Pituitary; 2015 Apr; 18(2):195-200. PubMed ID: 25647329
    [TBL] [Abstract][Full Text] [Related]  

  • 29. PATIENTS' PERCEPTION ON CLINICAL OUTCOME AND QUALITY OF LIFE AFTER A DIAGNOSIS OF CUSHING SYNDROME.
    Papoian V; Biller BM; Webb SM; Campbell KK; Hodin RA; Phitayakorn R
    Endocr Pract; 2016 Jan; 22(1):51-67. PubMed ID: 26437213
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Treatment effectiveness of pasireotide on health-related quality of life in patients with Cushing's disease.
    Webb SM; Ware JE; Forsythe A; Yang M; Badia X; Nelson LM; Signorovitch JE; McLeod L; Maldonado M; Zgliczynski W; de Block C; Portocarrero-Ortiz L; Gadelha M
    Eur J Endocrinol; 2014 Jul; 171(1):89-98. PubMed ID: 24760537
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Lack of functional remission in Cushing's syndrome.
    Vermalle M; Alessandrini M; Graillon T; Paladino NC; Baumstarck K; Sebag F; Dufour H; Brue T; Castinetti F
    Endocrine; 2018 Sep; 61(3):518-525. PubMed ID: 30019306
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Mental Fatigue and Executive Dysfunction in Patients with Cushing's Syndrome in Remission.
    Papakokkinou E; Johansson B; Berglund P; Ragnarsson O
    Behav Neurol; 2015; 2015():173653. PubMed ID: 26221060
    [TBL] [Abstract][Full Text] [Related]  

  • 33. ARE THERE RELIABLE PREDICTORS FOR THE IMPAIRED QUALITY OF LIFE IN PATIENTS WITH CUSHING'S SYNDROME?
    Nankova AB; Yaneva M; Elenkova A; Kalinov K; Zacharieva S
    Acta Endocrinol (Buchar); 2019; 15(4):482-490. PubMed ID: 32377246
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Significant GH deficiency after long-term cure by surgery in adult patients with Cushing's disease.
    Pecori Giraldi F; Andrioli M; De Marinis L; Bianchi A; Giampietro A; De Martin M; Sacco E; Scacchi M; Pontecorvi A; Cavagnini F
    Eur J Endocrinol; 2007 Feb; 156(2):233-9. PubMed ID: 17287413
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Assessment of health surveys: fitting a multidimensional graded response model.
    Depaoli S; Tiemensma J; Felt JM
    Psychol Health Med; 2018; 23(sup1):13-31. PubMed ID: 29544349
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cushing's syndrome: a structured short- and long-term management plan for patients in remission.
    Ragnarsson O; Johannsson G
    Eur J Endocrinol; 2013 Nov; 169(5):R139-52. PubMed ID: 23985132
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Quality of life in patients after long-term biochemical cure of Cushing's disease.
    van Aken MO; Pereira AM; Biermasz NR; van Thiel SW; Hoftijzer HC; Smit JW; Roelfsema F; Lamberts SW; Romijn JA
    J Clin Endocrinol Metab; 2005 Jun; 90(6):3279-86. PubMed ID: 15741267
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Disease-specific impairments in quality of life during long-term follow-up of patients with different pituitary adenomas.
    van der Klaauw AA; Kars M; Biermasz NR; Roelfsema F; Dekkers OM; Corssmit EP; van Aken MO; Havekes B; Pereira AM; Pijl H; Smit JW; Romijn JA
    Clin Endocrinol (Oxf); 2008 Nov; 69(5):775-84. PubMed ID: 18462264
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A direct comparison of quality of life in obese and Cushing's syndrome patients.
    Abraham SB; Abel BS; Rubino D; Nansel T; Ramsey S; Nieman LK
    Eur J Endocrinol; 2013 May; 168(5):787-93. PubMed ID: 23444412
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The longitudinal course of psychopathology in Cushing's syndrome after correction of hypercortisolism.
    Dorn LD; Burgess ES; Friedman TC; Dubbert B; Gold PW; Chrousos GP
    J Clin Endocrinol Metab; 1997 Mar; 82(3):912-9. PubMed ID: 9062506
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.